On Friday, Pediatrix Medical Group Inc (NYSE: MD) opened higher 0.62% from the last session, before settling in for the closing price of $14.44. Price fluctuations for MD have ranged from $6.62 to $17.67 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 2.58%. Company’s average yearly earnings per share was noted 7.65% at the time writing. With a float of $84.73 million, this company’s outstanding shares have now reached $85.81 million.
The extent of productivity of a business whose workforce counts for 6455 workers is very important to gauge. In terms of profitability, gross margin is 21.62%, operating margin of 7.27%, and the pretax margin is -5.03%.
Pediatrix Medical Group Inc (MD) Insider Updates
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Pediatrix Medical Group Inc is 1.36%, while institutional ownership is 96.16%. The most recent insider transaction that took place on Feb 21 ’25, was worth 308,093. Before that another transaction happened on Nov 13 ’24, when Company’s Director sold 27,600 for $15.35, making the entire transaction worth $423,660. This insider now owns 138,683 shares in total.
Pediatrix Medical Group Inc (MD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 7.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.05% during the next five years compared to 41.89% growth over the previous five years of trading.
Pediatrix Medical Group Inc (NYSE: MD) Trading Performance Indicators
Check out the current performance indicators for Pediatrix Medical Group Inc (MD). In the past quarter, the stock posted a quick ratio of 1.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.63. Likewise, its price to free cash flow for the trailing twelve months is 6.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.01, a number that is poised to hit 0.42 in the next quarter and is forecasted to reach 1.70 in one year’s time.
Technical Analysis of Pediatrix Medical Group Inc (MD)
The latest stats from [Pediatrix Medical Group Inc, MD] show that its last 5-days average volume of 1.43 million was superior to 0.68 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 89.39%. Additionally, its Average True Range was 0.58.
During the past 100 days, Pediatrix Medical Group Inc’s (MD) raw stochastic average was set at 45.20%, which indicates a significant decrease from 88.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.34% in the past 14 days, which was lower than the 52.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.76, while its 200-day Moving Average is $12.98. Now, the first resistance to watch is $14.82. This is followed by the second major resistance level at $15.12. The third major resistance level sits at $15.38. If the price goes on to break the first support level at $14.26, it is likely to go to the next support level at $14.00. Assuming the price breaks the second support level, the third support level stands at $13.70.
Pediatrix Medical Group Inc (NYSE: MD) Key Stats
There are currently 85,906K shares outstanding in the company with a market cap of 1.25 billion. Presently, the company’s annual sales total 2,013 M according to its annual income of -99,070 K. Last quarter, the company’s sales amounted to 502,360 K and its income totaled 30,480 K.
